Nov 30, 2016 9:00 AM

Dear Penn Medicine Colleague:

We write to alert you to a new Penn Medicine policy concerning the appropriate use of philanthropic funding in advancing clinical research efforts.  This policy is in effect immediately and will be administered by Penn Medicine's Institutional Review Board (IRB) in consultation with the offices of Development and General Counsel.

As a leading health care institution, we remain committed to the equitable selection of research subjects and the need to mitigate any perceived or real conflicts of interest associated with the inclusion of subjects into research conducted here.  While those with a history of past or anticipated future support for Penn Medicine remain fully eligible for participation in clinical research efforts, there should never be a link between an institutional gift and participation in clinical research.  The IRB and Development teams, therefore, have developed a short training module for researchers, medical professionals, and development staff detailing this policy and the important roles you all play in ensuring our collective efforts don't compromise the integrity of the scientific process. 
Please follow this link to access the training: https://upenn.app.box.com/s/dqjj6eplmm63t3j5djoil2hk5oh5wirh.

We encourage you to share this email and new donor policy module link with any of your colleagues directly involved in the planning and implementation of clinical research efforts at Penn Medicine.  And, please feel free to contact either of us if you have any questions about the policy.

Thank you for your time and attention to this important matter.

Tracy A. Ziolek
Director, Human Research Protections Program
Paul B. Mischler
Deputy Chief Advancement Officer
& Chief Operating Officer
Penn Medicine Development and Alumni Relations